PlasmaGen Biosciences completes INR 225 crores equity financing to drive growth from its state-of-the-art manufacturing facility for plasma products
Dec 15, 2023
Bengaluru (Karnataka) [India], December 15: PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, announced that...